A number of questions have been raised about the use of the US Environmental Protection Agency's Developmental Neurotoxicity Testing Guideline (DNTG) in the hazard identification of chemicals. The applicability and sensitivity of animal tests in the DNTG relative to human developmental neurotoxicity have recently been questioned. In a workshop held in 1989, participants compared the effects of several known developmental neurotoxicants in humans and animal models and concluded that the DNTG would have detected known human developmental neurotoxicants. They also concluded that although procedural differences may differ in the testing of humans and animals, the neurobiologic functions (ie, autonomic, sensory, motor, and cognitive) affected by chemical exposure were similar. In cases where the DNTG has been compared with other measures of reproductive and developmental toxicity, the DNTG has been relatively sensitive and specific. To date, DNTGs have been required 12 times, for 9 pesticides and 3 solvents. The sensitivity of the measures in the DNTG relative to other measures of developmental and adult toxicity supports the continued use of the DNTG in risk assessment.
Acuff KD, Vorhees CV (1998). Neurobehavioral teratology. In: Introduction to Neurobehavioral Toxicology: Food and Environment, Niesink RJM, Jaspers RMA , Kornet LMW, van Ree JM, Tilson HA (eds). CRC Press, New York, pp 27-69.
2.
Barnes DG, Dourson DG (1988). Reference dose (RfD): Description and use in human health risk assessments. Regul Toxicol Pharmacol8: 471-486.
3.
Barone S., Stanton ME, Mundy WR (1995). Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging. Neurobiol Aging16: 723-735.
4.
Calabrese EF (1985). Uncertainty factors and interindividual variation. Regul Toxicol Pharmacol5: 190-196.
5.
Dews PB ( 1986). On the assessment of risk. In: Developmental Behavioral Pharmacology, Krasnegor N, Gray T, Thompson T (eds). Erlbaum, Hillside, New Jersey, pp 53-65.
6.
Dourson ML, Felter SP, Robinson D. (1996). Evolution of science-based uncertainty factors in noncancer risk assessment. Regul Toxicol Pharmacol24: 108-120.
7.
Dourson ML, Stara JF (1983). Regulatory history and experimental support of uncertainty (safety) factors. Regul Toxicol Pharmacol3: 224-238.
8.
Faber WD, O'Donoghue JL (1991). Does the Chernoff-Kavlock screening assay for developmental neurotoxicity detect developmental neurotoxicants? Toxicologist11: 345A.
9.
Francis EZ, Kimmel CA, Rees DC ( 1990). Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: Summary and implications . Neurotoxicol Teratol12: 285-292.
10.
Goldey ES, Tilson HA, Crofton KM (1995). Implications of the use of neonatal birth weight, growth, viability, and survival data for predicting developmental neurotoxicity: A survey of the literature. Neurotoxicol Teratol17: 313-332.
Hattis D., Erdreich L., Ballew M. (1987). Human variability in susceptibility to toxic chemicals: A preliminary analysis of pharmacokinetic data from normal volunteers. Risk Anal7: 415-426.
13.
Hutchings DE (ed) (1989). Prenatal Abuse of Licit and Illicit Drugs, Vol 562. New York Academy of Science, New York.
14.
Kimmel CA (1988). Current status of behavioral teratology: Science and regulation. CRC Crit Rev Toxicol19: 1-10.
15.
Kimmel CA, Buelke-Sam J., Adams J. (1985). Collaborative behavioral teratology study: Implications, current applications and future directions. Neurobehav Toxicol Teratol7: 669-674.
16.
Kimmel C.A. , Rees DC, Francis EZ (1990). Qualitative and quantitative comparability of human and animal developmental neurotoxicity . Neurotoxicol Teratol12: 175-292.
17.
Kutscher CL , Sembrat M., Kutscher CS, Kutscher NL (1985). Effects of the high methyl mercury dose used in the Collaborative Behavioral Teratology Study on Brain Anatomy. Neurobehav Toxicol Teratol7: 775-777.
18.
Lochry EA (1987). Concurrent use of behavioral/functional testing in existing reproductive and developmental toxicity screens: Practical considerations . J Am Coll Toxicol6: 433-439.
19.
Makris S., Raffale K., Sette W., Seed J. ( 1998). A Retrospective Analysis of Twelve Developmental Neurotoxicity Studies Submitted to theUSEPAOffice of Prevention, Pesticides, and Toxic Substances (OPPTS). EPA Science Advisory Panel, Washington, D.C.
20.
National Academy of Sciences (NAS) (1988). Research on Children and Adolescents with Mental, Behavioral, and Developmental Disorders. National Academy Press, Washington, D.C.
21.
National Research Council (NRC) (1993). Pesticides in the Diets of Infants and Children . National Academy Press, Washington, D.C.
22.
Organization of Economic Cooperation and Development (OECD (1998) OECD Guideline for the Testing of Chemicals. Proposal for a New Guideline for Developmental Neurotoxicity Study. OECD, Washington, D.C.
23.
Rees DC, Francis EZ, Kimmel CA (1990). Scientific and regulatory issues relevant to assessing risk for developmental neurotoxicity: An overview. Neurotoxicol Teratol12: 175-181.
24.
Renwick AG (1998). Toxicokinetics in infants and children in relation to the ADI and TDI. Food Addit Contam15: 17-35.
25.
Renwick AG, Lazarus NR (1998). Human variability and noncancer risk assessment—An analysis of the default uncertainty factor. Regul Toxicol Pharmacol27: 3-20.
26.
Reuhl KR (1991). Delayed expression of neurotoxicity: The problem of silent damage. Neurotoxicology12: 341-346.
27.
Riley EP, Vorhees CV (eds) (1986). Handbook of Behavioral Teratology. Plenum, New York.
28.
Sheehan DM, Gaylor DW (1990). Analysis of the adequacy of safety factors. Teratology41: 590-591.
29.
Stanton ME, Spear LP (1990). Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: Comparability of measures of developmental neurotoxicity in humans and laboratory animals . Neurotoxicol Teratol12: 1-7.
30.
Ulbrich B., Palmer AK (1996). Neurobehavioral aspects of developmental toxicity testing. Environ Health Perspect.104: 407-412.
31.
US Environmental Protection Agency (EPA) ( 1991). Revised Neurotoxicity Test Guidelines for Pesticides . National Information Service, Washington, D.C.
32.
US Environmental Protection Agency (EPA) (1998). Health Effects Test Guidelines: Developmental Neurotoxicity Study. OPPTS 870.6300, EPA Document 712-C-98-239. EPA, Washington, D.C.
33.
US Environmental Protection Agency (EPA) (1998). Suggested Probabilistic Risk Assessment Methodology for Evaluating Pesticides with a Common Mechanism of Toxicity: Organophosphate Case Study. EPA Scientific Advisory Panel, Washington, D.C.
34.
Vorhees CV (1985). Behavioral effects of prenatal D-amphetamine in rats: A parallel trial to the Collaborative Behavioral Teratology Study. Neurobehav Toxicol Teratol7: 709-716.
35.
Vorhees CV (1985). Behavioral effects of prenatal methyl mercury in rats: A parallel trial to the Collaborative Behavioral Teratology Study . Neurobehav Toxicol Teratol7: 717-725.
36.
Vohees CV (1986). Comparison and critique of government regulations for behavioral teratology. In: Handbook of Behavioral Teratology , Riley EP, Vorhees CV (eds). Plenum, New York, pp 49-66.
37.
Wallinga D. (1998). Putting Children First: Making Pesticide Levels in Food Safer for Infants and Children. Natural Resources Defense Council, Washington, D.C.
38.
Wilson JG (1977). Embryotoxicity of drugs in man. In: Handbook of Teratology, Wilson JG, Fraser FC (eds). Plenum, New York, pp 309-355.
39.
World Health Organization (WHO) (1986). Draft Guidelines for the Assessment of Drugs and Other Chemicals for Behavioral Teratogenicity. WHO Regional Office for Europe, Copenhagen.
